Literature DB >> 8920981

Multiple factors regulating the expression of human thromboxane synthase gene.

K D Lee1, S J Baek, R F Shen.   

Abstract

Characterization of the 5.5 kb promoter of human thromboxane synthase (TS) gene revealed a proximal positive regulatory sequence (PPRS, -90 to -25 bp) and several distal repressive elements. The maximal promoter activity was found to reside within the first 285 bp, approximately 75% of which was contributed by the PPRS. The sequence between -365 and -665 bp exerted a strong repressive effect (approximately 55%) on reporter gene expression independent of orientation and position, consistent with properties expected for a silencer. The sequence upstream of -665 bp to -5.5 kb contains mainly repressive elements which further reduce the promoter activity by 30%. The 65 bp PPRS worked in an orientation-independent, but position-dependent, manner and could be further divided into two independent elements, PPRS1 (-90 to -50 bp) and PPRS2 (-50 to -25 bp). While similar nuclear factor(s) from different cell types interact with PPRS2, those interacting with PPRS1 exhibit cell specificity. Internal sequence deletion and oligonucleotide competition established that a binding sequence for NF-E2 in PPRS1 (-60 tgctgattcat -50) was important for enhancing TS promoter activity in HL-60 cells. The presence of NF-E2 mRNA in HL-60 cells was demonstrated by reverse-transcription PCR amplification of the cDNA and Northern blot analysis. A 9-fold transactivation of luciferase (luc) reporter gene expression had been detected when NF-E2 cDNA was co-expressed with a TS promoter/luc construct. Despite the fact that NF-E2 and the cis-elements could alter the efficiency of TS transcription, they were not sufficient for restricting cell-specific TS expression. Analysis of the methylation status at the TS promoter in several human cell lines reveals cell-specific patterns of methylation that might correlate with TS expression. Taken together, these results suggest that the expression of human TS gene is modulated by multiple factors including cis-elements, trans-activator(s), and possibly genomic methylation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8920981      PMCID: PMC1217857          DOI: 10.1042/bj3190783

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

Review 1.  Genomic imprinting: review and relevance to human diseases.

Authors:  J G Hall
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

2.  Identification and characterization of nuclear retinoic acid-binding activity in human myeloblastic leukemia HL-60 cells.

Authors:  C Nervi; J F Grippo; M I Sherman; M D George; A M Jetten
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

3.  Histochemical staining of clonal mammalian cell lines expressing E. coli beta galactosidase indicates heterogeneous expression of the bacterial gene.

Authors:  G R MacGregor; A E Mogg; J F Burke; C T Caskey
Journal:  Somat Cell Mol Genet       Date:  1987-05

4.  The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1.

Authors:  P Angel; K Hattori; T Smeal; M Karin
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

Review 5.  DNA methylation and gene activity.

Authors:  H Cedar
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

6.  The weak, fine-tuned binding of ubiquitous transcription factors to the Il-2 enhancer contributes to its T cell-restricted activity.

Authors:  B Hentsch; A Mouzaki; I Pfeuffer; D Rungger; E Serfling
Journal:  Nucleic Acids Res       Date:  1992-06-11       Impact factor: 16.971

7.  Parental imprinting: potentially active chromatin of the repressed maternal allele of the mouse insulin-like growth factor II (Igf2) gene.

Authors:  H Sasaki; P A Jones; J R Chaillet; A C Ferguson-Smith; S C Barton; W Reik; M A Surani
Journal:  Genes Dev       Date:  1992-10       Impact factor: 11.361

8.  Thromboxane A2 synthase. Modification during "suicide" inactivation.

Authors:  D A Jones; F A Fitzpatrick
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

Review 9.  Overview of physiological and pathophysiological effects of thromboxane A2.

Authors:  M L Ogletree
Journal:  Fed Proc       Date:  1987-01

10.  Inherited type of allelic methylation variations in a mouse chromosome region where an integrated transgene shows methylation imprinting.

Authors:  H Sasaki; T Hamada; T Ueda; R Seki; T Higashinakagawa; Y Sakaki
Journal:  Development       Date:  1991-02       Impact factor: 6.868

View more
  4 in total

1.  Glucocorticoid regulation of branched-chain alpha-ketoacid dehydrogenase E2 subunit gene expression.

Authors:  P A Costeas; J M Chinsky
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

2.  Reduced methylation of the thromboxane synthase gene is correlated with its increased vascular expression in preeclampsia.

Authors:  Ahmad A Mousa; Jerome F Strauss; Scott W Walsh
Journal:  Hypertension       Date:  2012-04-09       Impact factor: 10.190

3.  Expression of thromboxane synthase, TBXAS1 and the thromboxane A2 receptor, TBXA2R, in human breast cancer.

Authors:  Gareth Watkins; Anthony Douglas-Jones; Robert E Mansel; Wen G Jiang
Journal:  Int Semin Surg Oncol       Date:  2005-10-26

Review 4.  The Role and Regulation of Thromboxane A2 Signaling in Cancer-Trojan Horses and Misdirection.

Authors:  Anthony W Ashton; Yunjia Zhang; Rosanna Cazzolli; Kenneth V Honn
Journal:  Molecules       Date:  2022-09-22       Impact factor: 4.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.